Wed.Jul 20, 2022

article thumbnail

How to Promote a Culture of Belonging in Pharmacy

Pharmacy Times

Companies that incorporate Diversity, Equity, and Inclusion (DEI) into their everyday operations will be instrumental in shaping a new standard in their workforce and ultimately in society.

139
139
article thumbnail

Connecting your Digital Health Strategy from Clinical to Commercial

PharmExec

Thursday, July 21st 2022 at 11am EST, 8am PST, 5pm CEST Join this webinar to hear industry thought leaders discuss how data and experiences serve clinical and commercial needs, explore which platforms and technologies can enable a robust digital health ecosystem, and share recommendations for building a digital health strategy fit for your business.

139
139
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Putting an End to the Opioid Epidemic in Emergency Medicine

Pharmacy Times

What we're seeing as a trend is this significant increase in synthetic opioids, specifically fentanyl, being contaminated and causing severe overdoses.

149
149
article thumbnail

UK scientists say they have found cancer driver in junk DNA

pharmaphorum

It has suspected for many years that some diseases may be linked to non-coding or ‘junk’ DNA, but the mechanism behind the pathology hasn’t been worked out. Now, scientists in the UK think they have found a culprit implicated in cancer. Junk DNA is a term used to describe the 97% of the genetic sequence in human cells found between the 3% coding for our 20,000 genes, once thought to be inert.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Methotrexate Access Becomes Challenging for Some Patients Following Supreme Court Decision on Abortion

Pharmacy Times

Donald Miller, PharmD, discussed how the recent Supreme Court decision overturning Roe v. Wade has created confusion around access to methotrexate for patients in some states that are limiting abortion access.

132
132
article thumbnail

Prescribing shift for Pfizer’s Paxlovid expands access but draws questions

Pharmaceutical Technology

A key factor of Pfizer’s Covid-19 antiviral Paxlovid efficacy has been early intervention, but getting it in time has proven to be a challenge. On 6 July, in an effort to accelerate access, the US Food and Drug Administration (FDA) allowed pharmacists to also begin prescribing the drug to eligible individuals with Covid-19. Previously, only licensed and authorised physicians, advanced practice registered nurses, and physician assistants could prescribe the drug. .

Labelling 111

More Trending

article thumbnail

Gladstone and UCSF scientists discover BET protein role in Covid-19

Pharmaceutical Technology

Researchers at Gladstone Institutes and UC San Francisco (UCSF) have discovered in a study that bromodomain and extraterminal (BET) proteins are vital for the body to fight Covid-19 infection. . The research also found that BET proteins play two distinct roles in affecting how the SARS-CoV-2 virus interacts with human cells. . They provide the virus with a pathway into cells while aiding cells to defend themselves.

111
111
article thumbnail

Data Show Vabysmo Effective, Safe in Treatment of Wet Age-Related Macular Degeneration

Pharmacy Times

Treatment with faricimab-svoa (Vabysmo) may improve vision with fewer injections and treatment sessions for patients with wet age-related macular degeneration compared to other treatments.

123
123
article thumbnail

NA to NAM ratio as a biomarker for cell therapy sterility

European Pharmaceutical Review

Researchers have shown that ratio of nicotinic acid (NA) to nicotinamide (NAM) in cell cultures significantly increases with the presence of live microorganisms within 24 hours, acting as a useful biomarker for the detection of early-stage microbial contamination in cell therapies. Cell therapies are emerging as promising therapeutic modalities across a range of indications, with mesenchymal stromal cells (MSCs) the most clinically studied cell therapy platform worldwide; however, the nutrient r

95
article thumbnail

Examining the Public Health Impact of Pharmacies as Additional Sites for Rapid Diagnostic Testing

Pharmacy Times

Pharmacies and pharmacists are increasingly utilized for point-of-care (POC) services, including testing for infections that can be diagnosed via rapid testing.

122
122
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Cancer Research UK partnership aims to back 10 new startups

pharmaphorum

Cancer Research UK has expanded an alliance with investment group Deep Science Ventures with a commitment to support the formation up to 10 new oncology startups. London-based DSV has been working since 2019 with the charity’s Cancer Research Horizons unit, an incubator organisation which was set up to nurture new discoveries in academia and help to bring them to patients.

84
article thumbnail

Roche Launches Dual Antibody, Antigen Hepatitis C Virus Diagnostic Test Elecsys HCV

Pharmacy Times

Duo allows independent and simultaneous determination of early-stage infection and those who are recovering or showing signs of a chronic problem.

123
123
article thumbnail

Woman of the Week: Vaxxinity's Mei Mei Hu

PharmaVoice

Mei Mei Hu is looking to lead a third biologic ‘revolution’ by developing vaccines for chronic diseases.

article thumbnail

Study Results Suggest C. Difficile Drives Some Colorectal Cancers

Pharmacy Times

Analysis shows that the common infection may be a driver of the disease in adults younger than aged 50 years.

132
132
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

How can evidence-based medicine (EBM) methodology support drug withdrawals?

European Pharmaceutical Review

Withdrawing drugs over safety concerns requires careful analysis of the health benefits and risks by regulators. 1 But while data on adverse reactions is rightly used to help with these decisions, there is currently no additional modelling on the positive impact regulatory action could have on public health. Our research paper, which is being submitted for publication this summer, aims to create an evidence-based medicine (EBM) methodology that can assess this positive impact, to further help re

article thumbnail

Avadel Pharmaceuticals Receives Tentative Approval for Excessive Daytime Sleepiness Drug Lumryz

Pharmacy Times

Lumryz (FT218) treats cataplexy and excessive daytime sleepiness caused by narcolepsy.

123
123
article thumbnail

By the numbers: The rising danger of superbugs

PharmaVoice

A look at how the COVID-19 pandemic exacerbated one of the world’s greatest public health concerns.

98
article thumbnail

Pharmacy Technicians Burnout Increases as Role in Pharmacy Increases

Pharmacy Times

Donald Klepser, PhD, MBA, professor and dean of academic affairs at the College of Pharmacy in the University of Nebraska Medical Center, discusses how pharmacy technicians can manage their own stress and burnout.

73
article thumbnail

TSB and CR Pharma partner for Covid-19 antibody therapy in China

Pharmaceutical Technology

TSB Therapeutics, a joint venture (JV) majority-owned by Brii Biosciences (Brii Bio), has entered a collaboration with China Resources Pharmaceutical Commercial Group (CR Pharma) for the commercialisation of an antibody therapy, amubarvimab/romlusevimab combination, for Covid-19 in China. . Brii Bio developed the combination therapy in partnership with Tsinghua University and the 3rd People’s Hospital of Shenzhen.

article thumbnail

Tip of the Week: It’s All About Quality

Pharmacy Times

Quality refers to a set of systems that minimizes errors, maximizes performance and efficiency, and which provides the user with an optimal experience to receive the greatest health benefits.

65
article thumbnail

In A World Without PBMs

DiversifyRx

Does a world without PBMs seem blissful? . Close your eyes and just imagine what pharmacy would be like without PBMs. Are you joyous about the lack of audits, headaches, clawbacks, and DIR fees? Can you imagine your pharmacy profit soaring without PBMs? This fantasy seems pretty awesome, right? I am sorry to be the bearer of bad news. Even without PBMs, many pharmacy owners would still struggle. .

article thumbnail

Daily Medication Pearl: Hyqvia Immune Globulin Infusion 10%

Pharmacy Times

Hyqvia is an immune globulin with a recombinant human hyaluronidase indicated for the treatment of primary immunodeficiency in adults.

article thumbnail

Get an Early Start on Back to School Shopping!

Oswald's

Believe it or not, kids are going back to school in a month! Crazy, right? Even though a month may seem like plenty of time to get your kids what they need, you may want to get things now–while you still have a selection. Popular products and quality brands seem to sell out faster than… The post Get an Early Start on Back to School Shopping! appeared first on Oswald's Pharmacy.

52
article thumbnail

Daily OTC Pearl: Physician’s Choice Joint Support

Pharmacy Times

Physician’s Choice Joint Support helps with joint flexibility and repair, as well as a healthy inflammatory response.

65
article thumbnail

CAMP4 raises $100m to take lead RNA drugs into clinic

pharmaphorum

Armed with a $100 million second-round financing, CAMP4 Therapeutics is preparing to start the first clinical trial of a drug targeting regulatory RNA (regRNA) molecules that can be used to fine-tune the expression of genes. The Cambridge, Massachusetts biotech has discovered that areas of the non-coding parts of the human genome – referred to by its chief executive Josh Mandel-Brehm (pictured above) as the “dark side” of the genome – actually produce regRNAs that control the express

article thumbnail

Emphasis on Education for Cultural Competency for Pharmacists

Pharmacy Times

At the end of the day, we're interdisciplinary in terms of how it is that we need to manage our patients.

65
article thumbnail

The Challenges of Safety Risk Detection: The Automation Solution

Pharmaceutical Commerce

If there’s anything we learned from the pandemic, it’s the critical need to analyze patient outcome data in real time to stay informed on the safety and efficacy of treatments in the real world.

52
article thumbnail

Court won’t raise Seagen damages award in Enhertu patent dispute

pharmaphorum

A Texas court has confirmed the $41.8 million damages awarded to Seagen in its patent dispute with Daiichi Sankyo over beast cancer drug Enhertu, but declined to raise the sum despite concluding that the infringement was ‘wilful’ Seagen won a lawsuit in April which claimed that Enhertu (trastuzumab deruxtecan) infringes a patient it holds (No. 10,808,039) covering antibody-drug conjugates that include auristatin compounds coupled to an antibody via a linker molecule.

article thumbnail

Internet of things hiring levels in the pharmaceutical industry rose to a year-high in June 2022

Pharmaceutical Technology

The proportion of pharmaceutical companies hiring for internet of things related positions rose in June 2022 compared with the equivalent month last year, with 19.8% of the companies included in our analysis recruiting for at least one such position. This latest figure was higher than the 15.8% of companies who were hiring for internet of things related jobs a year ago and an increase compared to the figure of 19% in May 2022.

article thumbnail

The big squeeze?

pharmaphorum

With NHS England highlighting savings of £1.2 billion on medicines in three years coming from both deals on generics and new innovative treatments, Leela Barham takes stock of what we know about the impact on spending. As industry raises concerns about the multiple ways spend is managed – unsaid but pointing to a big squeeze on drug spending – she argues that industry will need to put together a strong evidence-based case to achieve change.

article thumbnail

How PSAOs Support Independent Pharmacies

Pharmacy Times

PSAO supports community pharmacies through patient access by unlocking the right payer agreements.

article thumbnail

Collaboration sets sights on acceleration of cystic fibrosis research

Outsourcing Pharma

Epistemic AI, Cincinnati Childrenâs Hospital Medical Center, and Boomer Esiason Foundation are working together to advance research into the rare disease.

article thumbnail

Access to C. difficile Treatments Presents Challenges During Transitions of Care

Pharmacy Times

This inflammation of the colon poses a substantial burden to patients and the health care system.

65
article thumbnail

Valproic Acid Clinical Pearls

Med Ed 101

Valproic acid is most commonly used for the management of seizures, bipolar disorder, and migraines. In my practice, I do see it occasionally used to help manage dementia-related aggressive behaviors. There are a lot of valproic acid clinical pearls that you need to remember, and I’m going to highlight some of the most important ones […].

40